Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Stoke Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
100
+3 vs. Q1 2023
Shares held
46.5M
+2.01M (+4.5%) vs. Q1 2023
Total value
$494.8M
+$122.9M (+33.1%) vs. Q1 2023
New holders
12
42 more added
Sold out
9
27 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting STOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 100 institutions
Q1 2021: 106 institutionsQ2 2021: 97 institutionsQ3 2021: 90 institutionsQ4 2021: 94 institutionsQ1 2022: 99 institutionsQ2 2022: 92 institutionsQ3 2022: 105 institutionsQ4 2022: 107 institutionsQ1 2023: 97 institutionsQ2 2023: 100 institutionsQ3 2023: 97 institutionsQ4 2023: 81 institutionsQ1 2024: 103 institutionsQ2 2024: 115 institutionsQ3 2024: 118 institutionsQ4 2024: 130 institutionsQ1 2025: 126 institutionsQ2 2025: 134 institutionsQ3 2025: 151 institutionsQ4 2025: 183 institutionsQ1 2026: 198 institutionsQ2 2026: 197 institutions
Value heldQ2 2023: $494.8M
Q1 2021: $1.49BQ2 2021: $680.3MQ3 2021: $492.4MQ4 2021: $849.6MQ1 2022: $870.6MQ2 2022: $569.4MQ3 2022: $544.4MQ4 2022: $371.8MQ1 2023: $371.8MQ2 2023: $494.8MQ3 2023: $173.1MQ4 2023: $236.9MQ1 2024: $731.7MQ2 2024: $828.5MQ3 2024: $715.5MQ4 2024: $640.4MQ1 2025: $421.6MQ2 2025: $744.0MQ3 2025: $1.57BQ4 2025: $2.13BQ1 2026: $2.31BQ2 2026: $2.49B
Institutions holding STOK and their total value by quarter
QuarterHoldersValue
Q2 2026197$2.49B
Q1 2026198$2.31B
Q4 2025183$2.13B
Q3 2025151$1.57B
Q2 2025134$744.0M
Q1 2025126$421.6M
Q4 2024130$640.4M
Q3 2024118$715.5M
Q2 2024115$828.5M
Q1 2024103$731.7M
Q4 202381$236.9M
Q3 202397$173.1M
Q2 2023100$494.8M
Q1 202397$371.8M
Q4 2022107$371.8M
Q3 2022105$544.4M
Q2 202292$569.4M
Q1 202299$870.6M
Q4 202194$849.6M
Q3 202190$492.4M
Q2 202197$680.3M
Q1 2021106$1.49B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Stoke Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding STOK in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
HRT Financial LP0$00.00%−69,440−100.0%Sold out
Jane Street Group, LLC0$00.00%−33,487−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−28,876−100.0%Sold out
Squarepoint Ops LLC0$00.00%−17,851−100.0%Sold out
Ergoteles LLC0$00.00%−16,871−100.0%Sold out
State Board of Administration of Florida Retirement System0$00.00%−10,473−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−9,409−100.0%Sold out
Group One Trading, L.P.0$00.00%−236−100.0%Sold out
Investors Research Corp0$00.00%−50−100.0%Sold out